{"id":"https://openalex.org/W3176713552","doi":"https://doi.org/10.1080/17460441.2021.1942834","title":"Advances in the discovery and development of melanoma drug therapies","display_name":"Advances in the discovery and development of melanoma drug therapies","publication_year":2021,"publication_date":"2021-06-23","ids":{"openalex":"https://openalex.org/W3176713552","doi":"https://doi.org/10.1080/17460441.2021.1942834","mag":"3176713552","pmid":"https://pubmed.ncbi.nlm.nih.gov/34157926"},"language":"en","primary_location":{"id":"doi:10.1080/17460441.2021.1942834","doi":"https://doi.org/10.1080/17460441.2021.1942834","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2021.1942834","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Monica Chanda","orcid":"https://orcid.org/0000-0003-1232-7759","observed_orcids":["https://orcid.org/0000-0003-1232-7759"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Chanda","raw_affiliation_strings":["Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":"https://orcid.org/0000-0003-1232-7759","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057675169","display_name":"Mark Steven Cohen","orcid":"https://orcid.org/0000-0002-2517-0757","observed_orcids":["https://orcid.org/0000-0002-2517-0757"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark S. Cohen","raw_affiliation_strings":["Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA","Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA","Department of Surgery, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":"https://orcid.org/0000-0002-2517-0757","affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Department of Surgery, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057675169"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":0.3997,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.35043263,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"16","issue":"11","first_page":"1319","last_page":"1347"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11249999701976776,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.8379999995231628},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7879999876022339},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5699999928474426},{"id":"https://openalex.org/keywords/nccn-guidelines","display_name":"NCCN guidelines","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cancer-treatment-costs","display_name":"cancer treatment costs","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7907214760780334},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.6098257303237915},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5884173512458801},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.544655442237854},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5154655575752258},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5141658782958984},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5045844316482544},{"id":"https://openalex.org/C3020580240","wikidata":"https://www.wikidata.org/wiki/Q663272","display_name":"Expert opinion","level":2,"score":0.45736488699913025},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4487164318561554},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43738648295402527},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28326261043548584},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19202464818954468},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10068365931510925}],"mesh":[{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/17460441.2021.1942834","doi":"https://doi.org/10.1080/17460441.2021.1942834","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2021.1942834","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},{"id":"pmid:34157926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34157926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3874440852","display_name":"New paradigms for Hsp90 inhibition","funder_award_id":"R01CA213566","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5267332074","display_name":"Optimization and Investigation of Cruentaren A analogs","funder_award_id":"R01CA216919","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8770490743","display_name":"Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors","funder_award_id":"R01CA120458","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309652","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W1565001940","https://openalex.org/W1915698186","https://openalex.org/W1975992327","https://openalex.org/W1982203628","https://openalex.org/W2009713492","https://openalex.org/W2024085992","https://openalex.org/W2038325530","https://openalex.org/W2038596114","https://openalex.org/W2050206485","https://openalex.org/W2058409986","https://openalex.org/W2063346434","https://openalex.org/W2090283325","https://openalex.org/W2093766287","https://openalex.org/W2099648846","https://openalex.org/W2114160093","https://openalex.org/W2118471749","https://openalex.org/W2121545342","https://openalex.org/W2154748904","https://openalex.org/W2335844855","https://openalex.org/W2340521152","https://openalex.org/W2345765068","https://openalex.org/W2416791964","https://openalex.org/W2461628610","https://openalex.org/W2525217971","https://openalex.org/W2543055468","https://openalex.org/W2544311982","https://openalex.org/W2548563255","https://openalex.org/W2558767962","https://openalex.org/W2563758465","https://openalex.org/W2592187743","https://openalex.org/W2605233023","https://openalex.org/W2617846385","https://openalex.org/W2726507447","https://openalex.org/W2752210999","https://openalex.org/W2752227448","https://openalex.org/W2756104107","https://openalex.org/W2773258053","https://openalex.org/W2775656051","https://openalex.org/W2789715646","https://openalex.org/W2790907672","https://openalex.org/W2791962996","https://openalex.org/W2792179496","https://openalex.org/W2793196876","https://openalex.org/W2793817570","https://openalex.org/W2794612508","https://openalex.org/W2794627893","https://openalex.org/W2797309423","https://openalex.org/W2802059438","https://openalex.org/W2806295244","https://openalex.org/W2887913814","https://openalex.org/W2888298425","https://openalex.org/W2891205725","https://openalex.org/W2895610076","https://openalex.org/W2896600825","https://openalex.org/W2900164408","https://openalex.org/W2903166095","https://openalex.org/W2939676267","https://openalex.org/W2939940798","https://openalex.org/W2942007182","https://openalex.org/W2946687934","https://openalex.org/W2947700061","https://openalex.org/W2948155539","https://openalex.org/W2950235098","https://openalex.org/W2965873243","https://openalex.org/W2977365200","https://openalex.org/W2977679516","https://openalex.org/W2988124258","https://openalex.org/W2994532011","https://openalex.org/W2997513295","https://openalex.org/W2997720498","https://openalex.org/W2998446840","https://openalex.org/W3001051725","https://openalex.org/W3003310139","https://openalex.org/W3004325705","https://openalex.org/W3006925540","https://openalex.org/W3013155032","https://openalex.org/W3015032733","https://openalex.org/W3037905349","https://openalex.org/W3089120188","https://openalex.org/W3134949487","https://openalex.org/W3135642192","https://openalex.org/W3135681687","https://openalex.org/W3153255378","https://openalex.org/W3181675264","https://openalex.org/W4253193856"],"related_works":["https://openalex.org/W7125693341","https://openalex.org/W3024538220","https://openalex.org/W4206492725","https://openalex.org/W2573278233","https://openalex.org/W2584102974","https://openalex.org/W2214943066","https://openalex.org/W2900730698","https://openalex.org/W4229019125","https://openalex.org/W2175881750","https://openalex.org/W4288050747"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Therapeutic":[1],"strategies":[2,52],"for":[3,45,88,145],"melanoma":[4,46,89],"have":[5,31,166],"evolved":[6],"significantly":[7],"over":[8],"the":[9,40,95,100,138],"last":[10],"decade":[11],"shifting":[12],"from":[13],"cytotoxic":[14],"chemotherapies":[15],"like":[16],"dacarbazine":[17],"to":[18,136],"targeted":[19],"therapies":[20,30,55,142],"and":[21,90,104,116,143,149,157,164,170,176],"immunotherapies":[22],"including":[23],"immune":[24],"checkpoint":[25],"inhibitors.":[26],"These":[27],"new":[28],"drug":[29,86],"improved":[32],"overall":[33],"as":[34,36,64,66,123,125],"well":[35,65,124],"progression-free":[37],"survival,":[38],"lowering":[39],"mortality":[41],"of":[42,61,71,85,94,98,140,153,173],"this":[43,146],"cancer":[44],"patients":[47,165],"with":[48],"advanced":[49],"disease.":[50],"Newer":[51],"incorporate":[53],"combination":[54,108],"that":[56],"harness":[57],"synergies":[58],"between":[59],"mechanisms":[60],"anticancer":[62],"efficacy":[63,102],"help":[67,161],"overcome":[68],"resistance":[69],"issues":[70],"monotherapies,":[72],"which":[73],"remain":[74],"a":[75,126,167],"challenge.":[76],"AREAS":[77],"COVERED:":[78],"This":[79],"review":[80],"looks":[81],"at":[82],"each":[83],"class":[84],"therapy":[87,109],"provides":[91],"an":[92],"overview":[93],"preclinical":[96],"mechanism":[97,152],"action,":[99,154],"clinical":[101],"data,":[103],"their":[105,151],"applications":[106],"in":[107],"regimens.":[110],"NCCN":[111],"treatment":[112,158,174],"guidelines,":[113],"safety,":[114],"toxicity,":[115],"immune-related":[117],"adverse":[118],"events":[119],"are":[120],"also":[121],"described":[122],"note":[127],"on":[128],"cost.":[129],"EXPERT":[130],"OPINION:":[131],"Numerous":[132],"ongoing":[133],"trials":[134],"continue":[135],"evaluate":[137],"role":[139],"novel":[141],"combinations":[144],"challenging":[147],"disease":[148],"understanding":[150],"risks,":[155],"benefits,":[156],"guidelines":[159],"can":[160],"care":[162],"providers":[163],"more":[168],"comprehensive":[169],"tailored":[171],"discussion":[172],"options":[175],"expectations.":[177]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-07-05T00:00:00"}